Strong but uneven spending in medical and health research and development across sectors over five-year period

November 20, 2018, Research!America

Total U.S. investment in medical and health research and development (R&D) in the U.S. grew by 27% over the five-year period from 2013 to 2017, led by industry and the federal government, according to U.S. Investments in Medical and Health Research and Development, a new report from Research!America. Industry accounted for 67% of total spending in 2017, followed by the federal government at 22%. The National Institutes of Health (NIH) accounted for the lion's share of federal spending in medical and health research in 2017 - $32.4 billion or 82.1%.

Academic and , including colleges and universities, independent research institutes (IRIs), and independent hospital medical research centers also increased , dedicating more than $14.2 billion of their own funds (endowment, donations, etc.) to medical and R&D in 2017. Other funding sources—foundations, state and local governments, voluntary health associations and professional societies—accounted for 3.7% of total medical and health R&D expenditures.

"Overall, U.S. investments in health-related research and development continue to move in a positive direction, but it's important to consider whether this is enough to overcome health threats that are taking lives, reducing productivity, and single-handedly placing our fiscal future at risk," said Research!America's Chair, the Honorable Michael N. Castle. "Other nations are investing in R&D hand over fist, so it's an economic competitiveness issue, too. We need to consider strategies for keeping the U.S. at the forefront even as we make more headway against deadly and costly health threats."

Biopharmaceutical companies contributed the largest share of funding within the industry sector, accounting for over 53% of total U.S. medical and health R&D expenditures in 2017. Of the top 25 U.S.-based pharmaceutical firms, 17 increased their spending, with eight spending more than $1 billion on pharmaceutical R&D that year. Increased investments in this sector may, in part, reflect the suspension of the medical device excise tax from 2016 to 2018.

Federal R&D investments were uneven across health agencies during the five-year period. The NIH received $2 billion increases in 2016 and 2017, but funding for other federal health agencies varied, with the Centers for Disease Control and Prevention and the Agency for Healthcare Research and Quality experiencing stagnant or reduced budgets over the last two years. Federal investments are expected to increase in the next two years due to the Bipartisan Budget Act of 2018, which lifted austerity-level budget caps for fiscal years 2018 and 2019. "Our nation cannot afford less than a full-court press against deadly and debilitating health threats. The returns—both quantitative and qualitative—on medical and health R&D dwarf our investment. It is heartening that we are on the right path, but it's time to dramatically step up our game," said Mary Woolley, president and CEO, Research!America. "Sequestration—automatic spending cuts—could return in 2020, resulting in deep cuts in federal agency budgets. It's more important than ever for advocates to engage policymakers to make the case for the increased investments needed from both public and private sectors in order to put and innovation to work at the level they can deliver to find the solutions to what ails us."

Explore further: Uneven growth in US medical and health R&D investments across sectors

Related Stories

Uneven growth in US medical and health R&D investments across sectors

November 10, 2017
Total U.S. investment in medical and health R&D in the U.S. grew by 20.6% from 2013 to 2016 led by industry and the federal government, according to U.S. Investments in Medical and Health Research and Development, a new report ...

New report: US investment in health research remains stagnant

September 8, 2011
The U.S. public and private sectors invested $140.5 billion in 2010 on research to find new ways to treat, cure and prevent disease and disability, according to Research!America's latest annual estimate, available at http://www.researchamerica.org/uploads/healthdollar10.pdf.

Total estimated cost of diagnosed diabetes $327 billion in 2017

March 28, 2018
(HealthDay)—The total estimated cost of diagnosed diabetes in 2017 was $327 billion, including $237 billion in direct medical costs, according to a study published online March 22 in Diabetes Care.

Federal parity tied to lower out of pocket mental health spending

August 4, 2018
(HealthDay)—Federal parity under the Mental Health Parity and Addiction Equity Act (MHPAEA) is associated with lower average annual out-of-pocket (OOP) mental health spending among children with mental health conditions, ...

1996 to 2013 saw large increase in diabetes spending

July 5, 2018
(HealthDay)—In 2013, $101 billion was spent in the United States on diabetes, almost a three-fold increase since 1996, according to a study published in the July issue of Diabetes Care.

Recommended for you

Hybrid prevalence estimation: Method to improve intervention coverage estimations

December 6, 2018
LSTM's Professor Joseph Valadez is senior author on a new study published today in the Proceedings of the National Academy of Sciences, which outlines proposals for a more accurate estimator of health data.

How algorithms can create inequality in health care, and how to fix it

December 5, 2018
Machine-learning algorithms and artificial intelligence software help organizations analyze large amounts of data to improve decision-making, and these tools are increasingly used in hospitals to guide treatment decisions ...

Healthcare providers—not hackers—leak more of your data

November 19, 2018
Your personal identity may fall at the mercy of sophisticated hackers on many websites, but when it comes to health data breaches, hospitals, doctors offices and even insurance companies are oftentimes the culprits.

How AI could help veterinarians code their notes

November 19, 2018
A team led by scientists at the School of Medicine has developed an algorithm that can read the typed-out notes from veterinarians and predict specific diseases that the animal may have.

Patients' experiences with misdiagnosis inform patient safety improvement efforts

November 6, 2018
Diagnostic errors affect an estimated 12 million U.S. adult outpatients annually; however, patients' experiences of these errors are underexplored. To gain insight into the patient perspective, researchers from Baylor College ...

Funder involved in all aspects of most industry-funded clinical trials

October 3, 2018
In most industry funded trials reported in high impact medical journals, all aspects of the trial involved the industry funder, finds a study published by The BMJ today.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.